| MeSH term | MeSH ID | Detail |
|---|---|---|
| Rickets, Hypophosphatemic | D063730 | 1 associated lipids |
| Calcium Metabolism Disorders | D002128 | 1 associated lipids |
| Anemia, Neonatal | D000751 | 1 associated lipids |
| Neurocysticercosis | D020019 | 1 associated lipids |
| Telangiectasia, Hereditary Hemorrhagic | D013683 | 1 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Herzberg M et al. | D-Glucaric acid and gamma-glutamyltransferase as indices of hepatic enzyme induction in pregnancy. | 1977 | Clin. Chem. | pmid:13946 |
| Tutor JC et al. | Serum copper concentration and hepatic enzyme induction during long-term therapy with anticonvulsants. | 1982 | Clin. Chem. | pmid:6122516 |
| Herzberg M and Wiener MH | Increased D-glucaric acid excretion by jaundiced patients. | 1978 | Clin. Chem. | pmid:699285 |
| Oka H et al. | Increased urinary excretion of L-xylulose in patients with liver cirrhosis. | 1976 | Clin. Chim. Acta | pmid:1248150 |
| Simmons CJ et al. | Urinary D-glucaric acid assay by an improved enzymatic procedure. | 1974 | Clin. Chim. Acta | pmid:4856673 |
| Jung K and Scholz D | Increased serum gamma-glutamyltransferase activity in renal transplant recipients: liver damage or microsomal enzyme induction? | 1984 | Clin. Chim. Acta | pmid:6147212 |
| Colombi A et al. | Low-pH method for the enzymatic assay of D-glucaric acid in urine. | 1983 | Clin. Chim. Acta | pmid:6851142 |
| Colombi A et al. | Influence of sex, age, and smoking habits on the urinary excretion of D-glucaric acid. | 1983 | Clin. Chim. Acta | pmid:6851143 |
| Ideo G et al. | Increased urinary D-glucaric acid excretion by children living in an area polluted with tetrachlorodibenzoparadioxin (TCDD). | 1982 | Clin. Chim. Acta | pmid:7074964 |
| Sandle LN and Braganza JM | An evaluation of the low-pH enzymatic assay of urinary D-glucaric acid, and its use as a marker of enzyme induction in exocrine pancreatic disease. | 1987 | Clin. Chim. Acta | pmid:3568402 |
| Marsillach J et al. | Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia. | 2007 | Clin. Exp. Pharmacol. Physiol. | pmid:17324148 |
| Hermida J et al. | Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment. | 2002 | Clin. Lab. | pmid:12146576 |
| Sirken G et al. | Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients. | 2006 | Clin. Nephrol. | pmid:17140164 |
| Silverberg DS et al. | The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization. | 2002 | Clin. Nephrol. | pmid:12227725 |
| Schwenk MH and Blaustein DA | Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients with severe anemia, iron deficiency and chronic kidney disease. | 2004 | Clin. Nephrol. | pmid:15356968 |
| Ciaccio EI and Fruncillo RJ | Urinary excretion of D-glucaric acid by severely burned patients. | 1979 | Clin. Pharmacol. Ther. | pmid:761444 |
| Ohnhaus EE et al. | Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin. | 1979 | Clin. Pharmacol. Ther. | pmid:35298 |
| Wright JH et al. | Hepatic enzyme induction patterns and phenothiazine side effects. | 1983 | Clin. Pharmacol. Ther. | pmid:6137306 |
| Perry W and Stamp TC | Urinary D-glucaric acid excretion during rifampicin/isoniazid and anticonvulsant enzyme induction. | 1984 | Clin. Pharmacol. Ther. | pmid:6143635 |
| Mustajoki P et al. | Rapid normalization of antipyrine oxidation by heme in variegate porphyria. | 1992 | Clin. Pharmacol. Ther. | pmid:1544288 |
| Breimer DD et al. | Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine. | 1977 | Clin. Pharmacol. Ther. | pmid:849678 |
| Reidenberg P et al. | Effects of felbamate on the pharmacokinetics of phenobarbital. | 1995 | Clin. Pharmacol. Ther. | pmid:7554701 |
| Sotaniemi EA et al. | Glucaric acid as an indicator of use of enzyme-inducing drugs. | 1974 | Clin. Pharmacol. Ther. | pmid:4150733 |
| Sorrell MF et al. | Paradoxical urinary excretion of D-glucaric acid in acute viral hepatitis. | 1976 | Clin. Pharmacol. Ther. | pmid:954355 |
| Lai AA et al. | Time-course of interaction between carbamazepine and clonazepam in normal man. | 1978 | Clin. Pharmacol. Ther. | pmid:688725 |
| Hopwood JJ and Muller V | Biochemical discrimination of Hurler and Scheie syndromes. | 1979 | Clin. Sci. | pmid:38945 |
| Bolton CH et al. | Enzyme induction and serum and lipoprotein lipids: a study of glutethimide in normal subjects. | 1980 | Clin. Sci. | pmid:7389270 |
| Yetman AT and Everitt MD | The role of iron deficiency in protein-losing enteropathy following the Fontan procedure. | 2011 Jul-Aug | Congenit Heart Dis | pmid:21392262 |
| Reed J et al. | The safety of intravenous iron sucrose use in the elderly patient. | 2007 | Consult Pharm | pmid:17658969 |
| Georgopoulos D et al. | Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. | 2005 | Crit Care | pmid:16277712 |
| van Iperen CE et al. | Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. | 2000 | Crit. Care Med. | pmid:10966249 |
| Corwin HL and Napolitano LM | Anemia in the critically ill: do we need to live with it?*. | 2014 | Crit. Care Med. | pmid:25126804 |
| Pieracci FM et al. | A multicenter, randomized clinical trial of IV iron supplementation for anemia of traumatic critical illness*. | 2014 | Crit. Care Med. | pmid:24797376 |
| Vanin S et al. | Seasonal variation of trehalose and glycerol concentrations in winter snow-active insects. | 2008 Nov-Dec | Cryo Letters | pmid:19280052 |
| Stein J et al. | Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator. | 2012 | Curr Med Res Opin | pmid:22181342 |
| Lee ES et al. | Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients. | 2013 | Curr Med Res Opin | pmid:23252876 |
| Cheng D et al. | A brief evaluation of tumor imaging in mice with 99mTc-glucarate including a comparison with 18F-FDG. | 2011 | Curr Radiopharm | pmid:22191610 |
| Clark SF | Iron deficiency anemia: diagnosis and management. | 2009 | Curr. Opin. Gastroenterol. | pmid:19262200 |
| Lorincz M et al. | Enzyme-generated intracellular fluorescence for single-cell reporter gene analysis utilizing Escherichia coli beta-glucuronidase. | 1996 | Cytometry | pmid:8866216 |
| Dornyei A et al. | Vanadium(IV,V) complexes of D-saccharic and mucic acids in aqueous solution. | 2004 | Dalton Trans | pmid:15381996 |
| Adjarov D et al. | [Clinical significance of D-glucaric of D-glucaric acid determination in the urine of porphyria cutanea tarda patients]. | 1985 | Dermatol Monatsschr | pmid:2861119 |
| Firoz BF et al. | Eosinophilic fasciitis secondary to intravenous iron infusions. | 2010 | Dermatol. Online J. | pmid:20492822 |
| Fontés G et al. | Involvement of Per-Arnt-Sim Kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic beta-cells. | 2009 | Diabetes | pmid:19502418 |
| Yi CX et al. | A major role for perifornical orexin neurons in the control of glucose metabolism in rats. | 2009 | Diabetes | pmid:19592616 |
| Rombouts K and Marra F | Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. | 2010 | Dig Dis | pmid:20460917 |
| Oyabu H et al. | Nonbacterial transformation of bilirubin in bile. | 1987 | Dig. Dis. Sci. | pmid:3608728 |
| Gasche C et al. | Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. | 1999 | Digestion | pmid:10343140 |
| Abdel-Razeq H et al. | Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study. | 2013 | Drug Des Devel Ther | pmid:24039403 |
| Affrime MB et al. | Failure of rifampin to induce the metabolism of clonidine in normal volunteers. | 1981 | Drug Intell Clin Pharm | pmid:7338192 |
| Nakamura Y et al. | Decreased valproate level caused by VPA-glucuronidase inhibition by carbapenem antibiotics. | 2008 | Drug Metab Lett | pmid:19356106 |